Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
100.0%
Previous 100.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$57.33 - $68.61 $0 - $0
0 New
0 $0
Q2 2024

Aug 14, 2024

SELL
$51.18 - $63.75 $2,047 - $2,550
-40 Closed
0 $0
Q3 2023

Oct 30, 2023

BUY
$57.77 - $65.93 $2,310 - $2,637
40 New
40 $2,000
Q1 2022

May 16, 2022

BUY
$66.02 - $79.71 $924 - $1,115
14 New
14 $1,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.4B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Psagot Value Holdings Ltd. Portfolio

Follow Psagot Value Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Psagot Value Holdings Ltd. , based on Form 13F filings with the SEC.

News

Stay updated on Psagot Value Holdings Ltd. with notifications on news.